Evidence hierarchy
Established and emerging treatments are discussed differently.
SKIN • REGENERATIVE • EVIDENCE-AWARE
A consultation-led review of regenerative and skin-quality options, with careful distinction between established treatments and emerging products.
ABOUT THE TREATMENT
Aesthetic medicine uses the term regenerative for treatments intended to support skin quality or tissue response, including options such as PRP and certain injectables. The evidence base differs substantially between products.
Your concern, relevant history and treatment goals are reviewed before suitability is discussed.
The treatment pathway is adapted to your assessment, priorities and realistic goals rather than a fixed protocol.
Technique, intensity and treatment details are selected conservatively according to the service and your individual needs.
Aftercare and follow-up are used to assess response, support recovery and decide whether further treatment is appropriate.
TREATMENT FOCUS
Treatment planning focuses on the factors most relevant to this service, your diagnosis or concern, and safe, realistic outcomes.
Established and emerging treatments are discussed differently.
For manufactured biologic products, source and regulatory status matter.
Treatment is matched to texture, hydration, scars or another specific concern rather than a vague “rejuvenation” promise.
Emerging regenerative options are considered cautiously with attention to evidence, product source and regulation.
IN MORE DETAIL
The safest approach is to define the concern, compare established and emerging options, and avoid claims that a procedure can reverse ageing or regenerate tissue beyond what evidence supports.
At Lumera Derm, treatment choice follows assessment. The aim is to match the option to the concern, skin or scalp condition, medical history and realistic goals rather than treating a service name as a one-size-fits-all solution.
YOUR VISIT
Each service follows the same principle: assess first, explain options clearly, then treat only when appropriate.
Discuss the concern, goals, relevant history and any previous treatment.
Confirm suitability, risks, alternatives and whether another pathway would be more appropriate.
Agree on a conservative, personalised plan with realistic expectations.
Follow-up is used to assess response and decide whether any further treatment is worthwhile.
SAFETY & SUITABILITY
Some products marketed as regenerative, particularly stem-cell or exosome products, may be unapproved or inadequately supported. Product-specific review is essential.
FREQUENTLY ASKED
Clear answers to common questions before you book.
BOOK A CONSULTATION
Ask questions, understand suitability and decide on the next step without unnecessary forms.